Axiom Investment Management’s Nu Skin NUS Stock Holding History

Axiom Investment Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$3K	–	304
2022 Q3	$3K	Buy	+100	New	+$4.16K	0.01%	319

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Axiom Investment Management's NUS Position: Q4 2022 in Review

Axiom Investment Management sold out of Nu Skin (NUS) in Q4 2022, closing a stake of 100 shares — an estimated $3K sold.

Axiom Investment Management first reported a position in NUS in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 218 funds tracked by Wall St. Rank hold NUS as of Q4 2022.

Axiom Investment Management reported no remaining Nu Skin position as of Q4 2022 after selling out during the quarter.
Axiom Investment Management sold 100 Nu Skin shares in Q4 2022, an estimated $3K.
Axiom Investment Management first reported a position in Nu Skin in Q3 2022 and held it in 1 quarter.
Axiom Investment Management's Nu Skin position peaked at $3K in Q3 2022.
218 funds tracked by Wall St. Rank held Nu Skin as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.